{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:29:42Z","timestamp":1793852982691,"version":"4.6.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.phrs.2021.105874","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T01:19:14Z","timestamp":1630977554000},"page":"105874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Acetyl-L-carnitine in chronic pain: A narrative review"],"prefix":"10.1016","volume":"173","author":[{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0369-1700","authenticated-orcid":false,"given":"Valeria","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-1515","authenticated-orcid":false,"given":"Simona","family":"Di Lascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Fornasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2021.105874_bib1","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s11064-017-2288-7","article-title":"L-Carnitine and acetyl-L-carnitine roles and neuroprotection in developing brain","volume":"42","author":"Ferreira","year":"2018","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25010182","article-title":"Carnitine in human muscle bioenergetics: can carnitine supplementation improve physical exercise?","volume":"25","author":"Gnoni","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2021.105874_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1320.003","article-title":"Kinetics, pharmacokinetics, and regulation of L-Carnitine and acetyl-L-carnitine metabolism","volume":"1033","author":"Rebouche","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: role in brain","volume":"49","author":"Jones","year":"2010","journal-title":"Prog. Lipid Res."},{"issue":"6","key":"10.1016\/j.phrs.2021.105874_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0891-5849(94)90197-X","article-title":"Postischemic inhibition of cerebral cortex pyruvate dehydrogenase","volume":"16","author":"Bogaert","year":"1994","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2021.105874_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0891-5849(93)90171-P","article-title":"Inhibition of postcardiac arrest brain protein oxidation by acetyl-l-carnitine","volume":"15","author":"Liu","year":"1993","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1475-2891-13-79","article-title":"Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial","volume":"13","author":"Lee","year":"2014","journal-title":"Nutr. J."},{"key":"10.1016\/j.phrs.2021.105874_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.phrs.2015.09.014","article-title":"Heme oxygenase-1, a novel target for the treatment of diabetic complications: focus on diabetic peripheral neuropathy","volume":"102","author":"Negi","year":"2015","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.phrs.2021.105874_bib9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2353\/ajpath.2008.070863","article-title":"Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans","volume":"173","author":"Almolki","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tem.2008.12.005","article-title":"Hsps and aging","volume":"20","author":"Tower","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.phrs.2021.105874_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","article-title":"Heat shock proteins and cancer","volume":"38","author":"Wu","year":"2017","journal-title":"Trends Pharm. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jnc.13590","article-title":"Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy","volume":"137","author":"Demarest","year":"2016","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.phrs.2021.105874_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jnr.20386","article-title":"Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2","volume":"79","author":"Calabrese","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.phrs.2021.105874_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hipo.20934","article-title":"Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1\/2-Nrf2-regulated mitochondrial biosynthesis","volume":"22","author":"Hota","year":"2012","journal-title":"Hippocampus"},{"issue":"9","key":"10.1016\/j.phrs.2021.105874_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03261931","article-title":"Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects","volume":"51","author":"Reuter","year":"2012","journal-title":"Clin. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2021.105874_bib16","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1046\/j.1471-4159.1998.70062613.x","article-title":"Ontogeny and cellular localization of the pyruvate recycling system in rat brain","volume":"70","author":"Cruz","year":"1998","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/19390211.2017.1359221","article-title":"L-carnitine and potential protective effects against ischemia-reperfusion injury in noncardiac organs: from experimental data to potential clinical applications","volume":"15","author":"Moghaddas","year":"2018","journal-title":"J. Diet. Suppl."},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000455041","article-title":"Neuroprotective effects of acetyl- L -carnitine on neonatal hypoxia ischemia-induced brain injury in rats","volume":"38","author":"Tang","year":"2017","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.phrs.2021.105874_bib19","first-page":"153","article-title":"Mechanisms of ischemic neuroprotection by acetyl-L-carnitine","volume":"Vol 1053","author":"Zanelli","year":"2005"},{"issue":"2","key":"10.1016\/j.phrs.2021.105874_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuropharm.2008.05.015","article-title":"Acetyl-l-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism","volume":"55","author":"Bagetta","year":"2008","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2021.105874_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01250574","article-title":"Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo","volume":"86","author":"Janiri","year":"1991","journal-title":"J. Neural Transm."},{"issue":"6","key":"10.1016\/j.phrs.2021.105874_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0197-0186(94)00162-N","article-title":"Effect of externally added carnitine on the synthesis of acetylcholine in rat cerebral cortex cells","volume":"26","author":"Wawrze\u0144czyk","year":"1995","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jnr.21815","article-title":"Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor","volume":"87","author":"Di Cesare Mannelli","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.phrs.2021.105874_bib24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1471-4159.2010.06807.x","article-title":"Metabolism of acetyl-l-carnitine for energy and neurotransmitter synthesis in the immature rat brain","volume":"114","author":"Scafidi","year":"2010","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1529-1006.00007","article-title":"\u201cBrain-specific\u201d nutrients: a memory cure?","volume":"3","author":"McDaniel","year":"2002","journal-title":"Psychol. Sci. Public Interest"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105874_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(97)00019-5","article-title":"Wallerian degeneration is required for both neuropathic pain and sympathetic sprouting into the DRG","volume":"72","author":"Ramer","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2021.105874_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105662","article-title":"Understanding pain perception through genetic painlessness diseases: the role of NGF and proNGF","volume":"169","author":"Testa","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2021.105874_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.04.024","article-title":"Pharmacology of nerve growth factor and discovery of tanezumab, an anti-nerve growth factor antibody and pain therapeutic","volume":"154","author":"Hefti","year":"2020","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1471-4892(01)00010-8","article-title":"Neurotrophic factors and neuropathic pain","volume":"1","author":"Boucher","year":"2001","journal-title":"Curr. Opin. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2021.105874_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nn2069","article-title":"Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury","volume":"11","author":"Wang","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105874_bib31","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.neuroscience.2010.03.017","article-title":"Acetyl-l-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy","volume":"167","author":"Vivoli","year":"2010","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.phrs.2021.105874_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and mechanisms of non-histone protein acetylation","volume":"20","author":"Narita","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2021.105874_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/0470862637.ch15","article-title":"Regulation of NF-kappaB action by reversible acetylation","volume":"259","author":"Greene","year":"2004","journal-title":"Novartis Found. Symp."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coph.2011.10.010","article-title":"Metabotropic glutamate receptors and the control of chronic pain","volume":"12","author":"Chiechio","year":"2012","journal-title":"Curr. Opin. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2021.105874_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tips.2009.12.003","article-title":"Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments for chronic pain","volume":"31","author":"Chiechio","year":"2010","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.phrs.2021.105874_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-8069-2-20","article-title":"Transcriptional regulation of metabotropic glutamate receptor 2\/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine","volume":"2","author":"Chiechio","year":"2006","journal-title":"Mol. Pain."},{"issue":"12","key":"10.1016\/j.phrs.2021.105874_bib37","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1073\/pnas.1216100110","article-title":"L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors","volume":"110","author":"Nasca","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.phrs.2021.105874_bib38","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0028-3908(02)00225-3","article-title":"Acetyl-l-carnitine induces muscarinic antinocieption in mice and rats","volume":"43","author":"Ghelardini","year":"2002","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2021.105874_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuropharm.2004.03.016","article-title":"Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception","volume":"47","author":"Galeotti","year":"2004","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3940(00)01023-5","article-title":"Blockade of pilocarpine-induced cerebellar phosphoinositide hydrolysis with metabotropic glutamate antagonists: evidence for an indirect control of granule cell glutamate release by muscarinic agonists","volume":"285","author":"Johnson","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.1993.tb23077.x","article-title":"Acetyl\u2010l\u2010carnitine and alzheimer\u2019s disease: pharmacological considerations beyond the cholinergic sphere","volume":"695","author":"CARTA","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105874_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.dmpk.2016.08.005","article-title":"Species specificity profiling of rat and human organic cation\/carnitine transporter Slc22a5\/SLC22A5 (Octn2\/OCTN2)","volume":"32","author":"Szab\u00f3","year":"2017","journal-title":"Drug Metab. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2021.105874_bib43","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/BF02980169","article-title":"HPLC determination and pharmacokinetics of endogenous acetyl-L-carnitine (ALC) in human volunteers orally administered a single dose of ALC","volume":"27","author":"Kwon","year":"2004","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00314926","article-title":"Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type","volume":"42","author":"Parnetti","year":"1992","journal-title":"Eur. J. Clin. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2021.105874_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030576","article-title":"An overview of crucial dietary substances and their modes of action for prevention of neurodegenerative diseases","volume":"9","author":"Poga\u010dnik","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155694","article-title":"Serum levels of Acyl-carnitines along the continuum from normal to alzheimer\u2019s dementia","volume":"11","author":"Cristofano","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12051389","article-title":"Acetyl-L-Carnitine in dementia and other cognitive disorders: a critical update","volume":"12","author":"Pennisi","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.phrs.2021.105874_bib48","first-page":"800","article-title":"Acetyl-l-carnitine for dementia (Review)","volume":"Apr","author":"Sa","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2021.105874_bib49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-200303000-00001","article-title":"Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer\u2019s disease","volume":"18","author":"Montgomery","year":"2003","journal-title":"Int Clin. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105874_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105542","article-title":"The receptor hypothesis and the pathogenesis of depression: Genetic bases and biological correlates","volume":"167","author":"Wang","year":"2021","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.phrs.2021.105874_bib51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-011-2326-0","article-title":"Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression","volume":"218","author":"Di Cesare Mannelli","year":"2011","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jpsychires.2014.02.005","article-title":"A review of current evidence for acetyl-l-carnitine in the treatment of depression","volume":"53","author":"Wang","year":"2014","journal-title":"J. Psychiatr. Res."},{"issue":"34","key":"10.1016\/j.phrs.2021.105874_bib53","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1073\/pnas.1801609115","article-title":"Acetyl- L -carnitine deficiency in patients with major depressive disorder","volume":"115","author":"Nasca","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.phrs.2021.105874_bib54","first-page":"101","article-title":"Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression","volume":"16","author":"Garzya","year":"1990","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.phrs.2021.105874_bib55","article-title":"Action of acetyl-L-carnitine in association with mianserine on depressed old people","volume":"3","author":"Nasca","year":"1989","journal-title":"New Trends Clin. Neuropharmacol."},{"key":"10.1016\/j.phrs.2021.105874_bib56","first-page":"1e12","article-title":"Acetyl-L-carnitine in depressed geriatric patients","volume":"6","author":"Villardita","year":"1993","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105874_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.euroneuro.2005.10.005","article-title":"A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia","volume":"16","author":"Zanardi","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2021.105874_bib58","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.euroneuro.2012.11.013","article-title":"L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine","volume":"23","author":"Bersani","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105874_bib59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lfs.2014.04.022","article-title":"Prophylactic role of acetyl-l-carnitine on knee lesions and associated pain in a rat model of osteoarthritis","volume":"106","author":"Bianchi","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2021.105874_bib60","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0038-1673679","article-title":"Neuropathic pain","volume":"38","author":"Macone","year":"2018","journal-title":"Semin. Neurol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105874_bib61","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1586\/14737175.2013.814930","article-title":"Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond","volume":"13","author":"Onofrj","year":"2013","journal-title":"Expert Rev. Neurother."},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1124\/mol.61.5.989","article-title":"L-acetylcarnitine induces analgesia by selectively upregulating mGlu2 metabotropic glutamate receptors","volume":"61","author":"Chiechio","year":"2002","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2021.105874_bib63","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917697009","article-title":"Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain","volume":"13","author":"Notartomaso","year":"2017","journal-title":"Mol. Pain"},{"issue":"8","key":"10.1016\/j.phrs.2021.105874_bib64","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1172\/JCI118621","article-title":"Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat","volume":"97","author":"Sima","year":"1996","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/exnr.1994.1117","article-title":"Acetyl-L-carnitine prevents age-dependent structural alterations in rat peripheral nerves and promotes regeneration following sciatic nerve injury in young and senescent rats","volume":"128","author":"De Angelis","year":"1994","journal-title":"Exp. Neurol."},{"issue":"15","key":"10.1016\/j.phrs.2021.105874_bib66","first-page":"5756","article-title":"Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine","volume":"9","author":"Pisano","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2021.105874_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2005.12.013","article-title":"Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy","volume":"397","author":"Flatters","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.phrs.2021.105874_bib68","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.ejca.2005.04.028","article-title":"Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine","volume":"41","author":"Bianchi","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phrs.2021.105874_bib69","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/JPR.S190231","article-title":"Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review","volume":"12","author":"Di Stefano","year":"2019","journal-title":"J. Pain Res."},{"issue":"4","key":"10.1016\/j.phrs.2021.105874_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00126839-200203040-00001","article-title":"Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy: A long-term, randomised, double-blind, placebo-controlled study","volume":"3","author":"De Grandis","year":"2002","journal-title":"Drugs R D"},{"issue":"6","key":"10.1016\/j.phrs.2021.105874_bib71","article-title":"Acetyl-l-carnitine for the treatment of diabetic peripheral neuropathy","volume":"6","author":"Rolim","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib72","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/jdi.12493","article-title":"Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: a multicenter, randomized, double-blind, controlled trial","volume":"7","author":"Li","year":"2016","journal-title":"J. Diabetes Investig."},{"issue":"12","key":"10.1016\/j.phrs.2021.105874_bib73","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40263-017-0476-2","article-title":"l-acetyl-carnitine in patients with carpal tunnel syndrome: effects on nerve protection, hand function and pain","volume":"31","author":"Cruccu","year":"2017","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.phrs.2021.105874_bib74","article-title":"Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.phrs.2021.105874_bib75","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.phrs.2021.105874_bib76","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-puttini","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.phrs.2021.105874_bib77","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/PRBM.S178240","article-title":"Psychological impact of fibromyalgia: current perspectives","volume":"12","author":"Galvez-S\u00e1nchez","year":"2019","journal-title":"Psychol. Res. Behav. Manag."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib78","first-page":"S39","article-title":"Potentially traumatic events, post-traumatic stress disorder and post-traumatic stress spectrum in patients with fibromyalgia","volume":"37","author":"Conversano","year":"2019","journal-title":"Clin. Exp. Rheuma"},{"issue":"7","key":"10.1016\/j.phrs.2021.105874_bib79","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00296-014-3208-7","article-title":"Fibrofog and fibromyalgia: a narrative review and implications for clinical practice","volume":"35","author":"Kravitz","year":"2015","journal-title":"Rheuma Int."},{"key":"10.1016\/j.phrs.2021.105874_bib80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.phrs.2021.105874_bib81","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3899\/jrheum.110026","article-title":"The longitudinal outcome of fibromyalgia: a study of 1555 patients","volume":"38","author":"Walitt","year":"2011","journal-title":"J. Rheuma"},{"issue":"7","key":"10.1016\/j.phrs.2021.105874_bib82","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","article-title":"Do we need a third mechanistic descriptor for chronic pain states?","volume":"157","author":"Kosek","year":"2016","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib83","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.10893","article-title":"Neurophysiologic evidence for a central sensitization in patients with fibromyalgia","volume":"48","author":"Desmeules","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib84","first-page":"152","article-title":"Hyperexcitability in fibromyalgia","volume":"25","author":"S\u00f6rensen","year":"1998","journal-title":"J. Rheuma"},{"issue":"6","key":"10.1016\/j.phrs.2021.105874_bib85","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib86","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/j.pain.0000000000000707","article-title":"Towards a neurophysiological signature for fibromyalgia","volume":"158","author":"L\u00f3pez-Sol\u00e0","year":"2017","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.phrs.2021.105874_bib87","first-page":"1453","article-title":"Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"57","author":"Duffield","year":"2018","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib88","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.semarthrit.2018.08.003","article-title":"A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis","volume":"48","author":"Grayston","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.phrs.2021.105874_bib89","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/j.pain.0000000000000311","article-title":"What is the meaning of \u201csmall fiber neuropathy\u201d in fibromyalgia?","volume":"156","author":"Clauw","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2021.105874_bib90","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mito.2015.01.010","article-title":"Oxidative stress, mitochondrial dysfunction and, inflammation common events in skin of patients with Fibromyalgia","volume":"21","author":"S\u00e1nchez-Dom\u00ednguez","year":"2015","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.phrs.2021.105874_bib91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1179\/1351000212Y.0000000036","article-title":"Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation","volume":"18","author":"Miyamae","year":"2013","journal-title":"Redox Rep."},{"issue":"7\u20138","key":"10.1016\/j.phrs.2021.105874_bib92","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.clinbiochem.2008.12.010","article-title":"Coenzyme Q10 distribution in blood is altered in patients with Fibromyalgia","volume":"42","author":"Cordero","year":"2009","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.phrs.2021.105874_bib93","doi-asserted-by":"crossref","first-page":"35677","DOI":"10.1371\/journal.pone.0035677","article-title":"Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q\u2081\u2080 effect on clinical improvement","volume":"7","author":"Cordero","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2021.105874_bib94","first-page":"295","article-title":"Fibromyalgia and psychiatric comorbidity: their effect on the quality of life patients","volume":"38","author":"Gonz\u00e1lez","year":"2010","journal-title":"Actas Esp. Psiquiatr"},{"key":"10.1016\/j.phrs.2021.105874_bib95","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9724371","article-title":"The link between depression and chronic pain: neural mechanisms in the brain","volume":"2017","author":"Sheng","year":"2017","journal-title":"Neural Plast."},{"issue":"2","key":"10.1016\/j.phrs.2021.105874_bib96","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.archger.2007.03.012","article-title":"Acetyl l-carnitine (ALC) treatment in elderly patients with fatigue","volume":"46","author":"Malaguarnera","year":"2008","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"10","key":"10.1016\/j.phrs.2021.105874_bib97","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.dld.2007.06.013","article-title":"L-Carnitine in the treatment of fatigue in adult celiac disease patients. A pilot study","volume":"39","author":"Ciacci","year":"2007","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.phrs.2021.105874_bib98","first-page":"182","article-title":"Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients","volume":"25","author":"Rossini","year":"2007","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.phrs.2021.105874_bib99","first-page":"S82","article-title":"A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data","volume":"33","author":"Leombruni","year":"2015","journal-title":"Clin. Exp. Rheuma"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821004588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821004588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T01:48:39Z","timestamp":1734400119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821004588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":99,"alternative-id":["S1043661821004588"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105874","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetyl-L-carnitine in chronic pain: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105874"}}